Without adequate treatment and management, people with diabetes face significantly reduced quality of life. On World Diabetes Day, EFPIA is happy to support the Diabetes Community's pledge and continue to work together to improve people’s lives.

Under the current EU Commission's pharma legislative proposals, Europe risks losing a third of its share of global R&D by 2040, increasing the EU's reliance on other regions for innovation. Discover more here.

iCARE4CVD is an international, public-private research project that brings together 33 academic and industry partners united in the pursuit of improving the health of patients with CVD. The project will run for 4.5 years, led by University of Maastricht and Novo Nordisk.

Discover more on icare4cvd.eu

Nathalie Moll, EFPIA Director General, and Jacky Vonderscher, CEO of ENYO Pharma, joined the 2023 FT Global Pharma and Biotech Summit to discuss the opportunities for both big pharma companies and SMEs operating in Europe, considering the upcoming legislative changes.

Watch the event recording.